IgA Nephropathy Market

IgA nephropathy sales will expand through 2036, with primary IgA nephropathy at 81.0% of the disease type category and hospitals at 62.1% of end-user demand in 2026. The market was valued at USD 46.82 billion in 2025 and is forecast to record a 7.6% CAGR between 2026 and 2036.